AXNX Long Entries

2021년 3월 31일

Surgical devices/equipment and surgically implanted devices may face a drastic increase in demand this coming quarter with the resumption of all elective procedures. During covid 19 many hospitals were forced to limit surgeries ( like insertions of AXNX's sacral neuromodulation device) to provide extra beds/resources to cope with the pandemics issues. A break out of a bullish cup n handle type formation on large volume to new ATH's today provide an attractive entry point. More demand catalysts for the stimulator include an aging population and MRI compatibility. Last reported earnings I saw jumped from 5million to 23 million. Good luck to all and may the market gods be with you